1. A Novel Von Hippel–Lindau Case With Germline Mutation at Codon 167 (CGG to TGG) Having Endocrine Microadenomatosis of the Pancreas
- Author
-
Kaori Kameyama, Koichi Aiura, Masakazu Ueda, Masaki Kitajima, Tomotaka Akatsu, and Yasuhiro Ito
- Subjects
Adult ,medicine.medical_specialty ,von Hippel-Lindau Disease ,endocrine system diseases ,Adenoma ,Physiology ,Population ,Biology ,urologic and male genital diseases ,Diagnosis, Differential ,Germline mutation ,Internal medicine ,Multiple Endocrine Neoplasia Type 1 ,medicine ,Humans ,Missense mutation ,Endocrine system ,MEN1 ,Codon ,Multiple endocrine neoplasia ,education ,Germ-Line Mutation ,education.field_of_study ,Gastroenterology ,Adenoma, Islet Cell ,medicine.disease ,female genital diseases and pregnancy complications ,Pancreatic Neoplasms ,Endocrinology ,medicine.anatomical_structure ,Cancer research ,Female ,Tomography, X-Ray Computed ,Pancreas - Abstract
Endocrine tumors of the pancreas are uncommon. They occur in approximately 1 in 100,000 of the population and represent 1–2% of all pancreatic neoplasms. The tumors show no significant gender predilection and occur at all ages, with a peak incidence between 30 and 60 years. Some may be part of the multiple endocrine neoplasia type 1 (MEN1) and von Hippel-Lindau (VHL) disease. Microadenomatosis represents the presence of multiple small endocrine tumors in the pancreas [1]. Microadenomatosis of the endocrine pancreas is a hallmark of MEN1 syndrome [2, 3]. Interestingly, this condition is rarely described in a non-MEN1 setting [4, 5]. We herein report a unique case of pancreatic microadenomatosis occurring in a nonfamilial VHL disease patient with renal cell carcinoma (RCC). Moreover, genetic analysis for the VHL gene showed a missense mutation at the codon 167 (Arg167Trp, heterozygous) in this case. The type of VHL mutation has been reported to correlate with the clinical manifestations of the disease [6–9], and we also discuss this issue.
- Published
- 2007
- Full Text
- View/download PDF